The Cooper Companies, Inc.

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +35

Cooper Companies (COO) Faces A CEO Exit, Is The Stock Still Cheap?

Company update Leadership change AI-generated analysis

πŸ‘” Cooper Companies is undergoing a leadership change as Albert White steps down as CEO and Walter Rosebrough assumes the role of executive chair.

πŸ“‰ The stock has declined 16.57% over the past 90 days and 13.69% in total shareholder return over one year, reflecting investor caution despite recent gains.

πŸ’° Cooper Companies reported record free cash flow in Q3 2026 and reiterated guidance for approximately US$2.2 billion in free cash flow from 2026 to 2028.

πŸš€ The company is implementing operational streamlining efforts including shared services, restructuring, and AI-enabled inventory optimization to boost efficiency.

πŸ’Ž Analysts calculate a fair value of $66.21 for Cooper Companies, suggesting the current price of $60.34 may be undervalued relative to projected cash generation.

🌏 Investors are concerned about ongoing softness in the Asia Pacific region which could continue to drag on the company's results.

βš–οΈ The stock faces specific risks related to legacy hydrogel rationalization and potential escalation of legal issues involving its CooperSurgical division.

Bullish Signals
  • Cooper Companies reported record free cash flow in Q3 2026, demonstrating strong underlying financial performance despite leadership changes.
  • Management has reiterated robust guidance for approximately US$2.2 billion in free cash flow over the 2026 to 2028 period, supporting future growth expectations.
  • The company is actively streamlining operations through shared services, restructuring, and AI-enabled inventory optimization to improve working capital efficiency.
  • Analysts assign a fair value of $66.21 to the stock, indicating that the current price of $60.34 may not fully reflect its projected cash generation and premium lens focus.
Risk Factors
  • The company faces ongoing softness in the Asia Pacific region which is expected to continue dragging on its results.
  • Legacy hydrogel rationalization efforts present a risk that could impact the company's financial performance in the near term.
Full Analysis
Cooper Companies (COO) is navigating a significant leadership transition following the departure of President and CEO Albert White, with Board member Walter Rosebrough stepping in as executive chair to oversee daily operations. Despite this structural change, recent trading data indicates investor caution, evidenced by a 16.57% decline over the past 90 days and a 13.69% drop in total shareholder return over one year, even though the stock has gained 6.74% in the last month. Analysts view Cooper Companies as a quality healthcare player currently undervalued at approximately $60.34, with a calculated fair value of $66.21 based on projected cash generation and its premium lens focus. The company is executing operational streamlining initiatives, including shared services, restructuring, and AI-enabled inventory optimization, which contributed to record free cash flow in Q3 2026. Management has reiterated guidance for roughly US$2.2 billion in free cash flow over the 2026 to 2028 period, creating potential for improved working capital efficiency and stronger net margins. However, bulls and bears remain divided on the stock's trajectory, with concerns lingering regarding softness in the Asia Pacific region, legacy hydrogel rationalization challenges, and potential escalation of legal issues involving its CooperSurgical division.